EUE. A. Ulesova

E. A. Ulesova

*This is an algorithmically generated author record based on publicly available information.

E. A. Ulesova has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    SMART 2.0 Scale for Quantitative Assessment of Anatomical and Functional Complexity in Patients with Cicatricial Tracheal Stenosis: Development and Primary Validation

    by M. A. Ursov, A. V. Mariyko, A. V. Parshin, D. D. Serpukhin, E. A. Ulesova, E. G. Sokolovich, V. D. Parshin, М. А. Урсов, А. В. Марийко, А. В. Паршин, et al.

    Background: In cicatricial tracheal stenosis, treatment complexity is determined by the anatomy of the lesion and previous interventions. A quantitative assessment of these features is necessary to compare patients and follow changes during treatment. Objective: To evaluate the SMART 2.0 scale and its association with treatment modalities and outcomes, and to describe changes in scores across successive hospitalizations. Material and methods: A registry of 1209 patients who underwent surgery by a single surgical team in 2004–2024 was analyzed retrospectively. The five SMART 2.0 domains integrate clinical history and current findings in a score of 0–20 points. The registered analysis plan (https://osf.io/65zxb) used Jonckheere–Terpstra and Cochran–Armitage tests and area under the ROC curve (AUC). Results: The median baseline SMART 2.0 score increased from 6.5 (5–8) in the isolated endoscopic treatment category to 9 (7–10) in the category combining resection with staged tracheoplasty (z = 9.213; p < 0.001). AUC was 0.60 (95% CI, 0.56–0.65) for the full composite and 0.55 (0.49–0.60) after removing the hospitalization-count component, with no monotonic frequency trend ( p = 0.104). An unfavorable final status was recorded in 25 of 820 patients; AUC was 0.63 (0.52–0.74). Discussion: Higher baseline scores corresponded to more staged treatment. Combining clinical history with current anatomy provides a way to describe the postoperative situation while retaining information on prior treatment. Predictive performance was limited: AUC was below the registered criterion of 0.70 for both outcomes. Conclusion: SMART 2.0 warrants further evaluation as a standardized description of complexity during treatment for cicatricial tracheal stenosis. The score showed preliminary correspondence with treatment categories within one team. The prognostic hypotheses were not confirmed; independent validation is needed for treatment decisions and assessment of clinically meaningful change.

  • Restenosis rate after surgical and endoscopic treatment of cicatricial tracheal stenosis: a systematic review and meta-analysis

    by M.A. Ursov, A.V. Mariiko, A.V. Parshin, D.D. Serpukhin, E.A. Ulesova, E.G. Sokolovich, V.D. Parshin

    Objective. To estimate the rate of restenosis after surgical and endoscopic treatment of acquired benign tracheal stenosis in adults with separate analyses by approach, etiology, and follow-up. Material and methods. Systematic searching was performed in PubMed/MEDLINE, EuropePMC, Cochrane CENTRAL, eLibrary.ru, BASE, LILACS databases and trial registries (2005–2025). Cohorts ≥100 patients (primary set) and 50–99 (sensitivity set) were eligible. Two reviewers performed blinded screening and extraction (Cohen’s κ=0.808); the risk of bias was assessed with ROBINS-I. Proportions were pooled under random effects with stratification by approach, etiology and follow-up. Results. Primary set comprised 14 cohorts (3.213 patients; 690 events); sensitivity set — 25 cohorts. Heterogeneity was high (I²=98.0%). The pooled restenosis rate was 16.8% (95% CI 13.5–20.6; 95% PI 1.1–78.2). There were the following values depending on approach: circumferential tracheal resection 7.8%, mixed 10.0%, isolated endoscopy 47.6% (p<0.0001). Idiopathic subglottic cicatricial stenosis of the trachea comprised 58.9%, PITS+PTTS — 5.7%, mixed/other — 15.3% (p<0.0001). Sensitivity set yielded 22.3%. The estimate was robust to sequential cohort exclusion (16.5–25.2%). Egger’s test showed funnel asymmetry (p=0.019) opposite to classical small-study pattern; trim-and-fill imputed no missing studies. Conclusion. The pooled 16.8% does not predict individual outcome; only the stratified estimate is clinically usable. Direct surgical-versus-endoscopic comparison on retrospective data is unsound because patient selection differs by approach. In idiopathic subglottic stenosis, the true restenosis rate under adequate prospective follow-up exceeds the primary-set estimate.